NORWOOD, MA, (PRWEB) October 10, 2006 –-
With an existing healthcare portfolio of more than 15 major clients in the pharmaceutical, biotechnology and medical devices industries, Cramer today announced the formal creation of a new, wholly-focused Healthcare Practice. This is the first time in the Company’s 20+ year history it has formed a practice dedicated to developing and offering specialized services within, and exclusively for, a major specialized market.
Over the past five years, Cramer has established a reputation as a leading provider of integrated marketing services specific to the healthcare industry. The company has won numerous awards recognizing its success in helping its heathcare clients create stronger, more credible and long-lasting connections to key consumer, patient and professional audiences.
Through Cramer’s understanding of brand lifecycle strategies, ranging from early disease awareness to patient compliance, retention and advocacy opportunities, the company has been able to continually deliver superior, measurable results. Cramer specializes in the development of strategies that facilitate personalized conversations between consumers/patients with physicians and sales representatives with professional communities.
Cramer’s newly formed Healthcare Practice is focused on three primary solution categories.
o Marketing to Consumers/Patients
o Marketing to Professionals
o Training & Sales Communications
Cramer’s entire set of capabilities, including strategic and tactical planning, positioning and brand development, online and offline marketing, sales training, presentations and collateral, tradeshow marketing, and interactive design support these solution categories. Cramer also helps its clients analyze and measures marketing performance to ensure that components are performing to optimize return on investment and experience.
In making today’s announcement, the Company said it believes the newly-formed practice will offer unique advantages in three specific market segments:
o Mid- to large-sized pharmaceutical and biotechnology companies
o Medical device and diagnostic companies
o Emerging biotechnology companies as well as other healthcare start-ups.
Of the three targeted areas, the mid-sized pharmaceutical opportunity is currently believed to be where the new division will most quickly add to its success of the past five years.
Major Allocation of Personnel Resources
Cramer also announced today that Vice President Liz Kay will head the new division. A five-year senior executive with the Company, Kay has been focused on establishing and expanding the organization’s rapid growth in strategic healthcare program development. With more than 25 years’ experience in strategic planning and integrated marketing, Kay has helped expand the company’s healthcare clientele, which includes such companies as Bayer Healthcare, Boston Scientific, Genzyme, Novartis, Philips Medical Systems, Serono, Inc., and US Surgical.
In 2006, Kay was named to the Board of Directors of the Boston Chapter of the Healthcare Businesswomen’s Association (HBA). Kay is also an active member of the Boston Club. Kay is supported by a senior team, comprised of strategic, creative and content specialists with award-winning experience in developing integrated marketing communications programs. In addition to these key team leads, Cramer’s new healthcare practice is supported by the firm’s 180-person staff of strategic, creative and marketing professionals.
Cramer is a leading independent provider of integrated marketing solutions with a 20-year-plus history and reputation for tactical creativity, integrity, agility and accountability. The company delivers business results through targeted marketing campaigns in the areas of Brand Development, Product Launches, Sales and Product Training, Internal Communications, Channel Marketing, Customer Acquisition and Retention, and Meetings and Events. Cramer's core service offerings include: Strategic Planning, Events, Graphic Design, Interactive, Learning Solutions, and Video. Cramer's portfolio of clients crosses multiple vertical markets and spans local, regional, national, and global geographies. The Company is privately-held.